GLP-1 medications were one of the hottest topics in healthcare in 2023, and interest in the weight-loss medications is only expected to increase, which will likely result in different approaches from leading companies.Eli Lilly’s Zepbound was the most recent injectable anti-obesity medication to burst onto the scene in November after FDA approval, joining an ever-growing […]